Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
PMV Pharmaceuticals, Inc
Kivu Bioscience Inc.
NeoImmuneTech
BeOne Medicines
Neonc Technologies, Inc.
Eli Lilly and Company
AstraZeneca
Radiopharm Theranostics, Ltd
NiKang Therapeutics, Inc.
MacroGenics
AstraZeneca
SystImmune Inc.
SN BioScience
Radiopharm Theranostics, Ltd
ImmunityBio, Inc.
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
NiKang Therapeutics, Inc.
Merck Sharp & Dohme LLC
Pfizer
Pfizer
Incyte Corporation
A2 Biotherapeutics Inc.
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
Klus Pharma Inc.
Theratechnologies
Inspirna, Inc.
Cofactor Genomics, Inc.
Cybrexa Therapeutics
Sotio Biotech Inc.
Cyteir Therapeutics, Inc.
Carisma Therapeutics Inc
Tasly Biopharmaceuticals Co., Ltd.
Travera Inc
Sellas Life Sciences Group
Vincerx Pharma, Inc.
AstraZeneca
Salubris Biotherapeutics Inc
Merck Sharp & Dohme LLC
Xencor, Inc.
Advaxis, Inc.
Exelixis
Evopoint Biosciences Inc.
AstraZeneca
Shanghai Yunying Medical Technology
Fate Therapeutics